Impact of hemoadsorption with CytoSorb® on meropenem and piperacillin exposure in critically ill patients in a post-CKRT setup: a single-center, retrospective data analysis

Impact of hemoadsorption with CytoSorb® on meropenem and piperacillin exposure in critically ill patients in a post-CKRT setup: a single-center, retrospective data analysis

Abstract Purpose CytoSorb® (CS) adsorbent is a hemoadsorption filter for extracorporeal blood purification often integrated into continuous kidney replacement therapy (CKRT). It is primarily used in critically ill patients with sepsis and related conditions, including cytokine storms and systemic in...

Full description

Bibliographic Details
Main Authors: Golschan Asgarpur, Franz Weber, Peggy Kiessling, Nilufar Akbari, Fabian Stroben, Bernadette Kleikamp, Charlotte Kloft, Sascha Treskatsch, Stefan Angermair
Format: Article
Language:English
Published: SpringerOpen 2025-01-01
Series:Intensive Care Medicine Experimental
Subjects:
CytoSorb®
Extracorporeal therapy
Hemoadsorption
Therapeutic drug monitoring (TDM)
Meropenem
Piperacillin/tazobactam
Online Access:https://doi.org/10.1186/s40635-025-00716-0

Internet

https://doi.org/10.1186/s40635-025-00716-0

Similar Items